An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer

• Asıl Yazarlar: C. Pinto-Díez (Yazar), R. Ferreras-Martín (Yazar), R. Carrión-Marchante (Yazar), J.I. Klett-Mingo (Yazar), M. García-Hernández (Yazar), M.I. Pérez-Morgado (Yazar), S. Sacristán (Yazar), M. Barragán (Yazar), M. Seijo-Vila (Yazar), I. Tundidor (Yazar), S. Blasco-Benito (Yazar), E. Pérez-Gómez (Yazar), I. Gómez-Pinto (Yazar), C. Sánchez (Yazar), C. González (Yazar), V.M. González (Yazar), M.E. Martín (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2022-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Breast cancer is the most commonly diagnosed and leading cause of cancer death among women worldwide. Mitogen-activated protein kinase-interacting kinases (MNKs) promote the expression of several oncogenic proteins and are overexpressed in several types of cancer. In human cells, there are four isof...